Form 4: Hims & Hers CFO Earns 410,690 Performance-Based Shares

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, earned 410,690 shares of Class A Common Stock through performance-based restricted stock units.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., acquired 410,690 shares of Class A Common Stock.
• These shares were earned as performance-based restricted stock units (PRSUs) after the Compensation Committee certified that performance criteria were met as of February 23, 2026.
• The shares are expected to be delivered to Mr. Okupe on or about March 15, 2026.
• Following this transaction, Mr. Okupe beneficially owns 502,307 shares directly and 7,853 shares indirectly through the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive indicator, as the CFO's earning of performance-based shares suggests the company met specific internal performance criteria, aligning executive incentives with shareholder value.

Positives

• The Chief Financial Officer earned a significant number of shares (410,690) through performance-based restricted stock units, indicating successful achievement of pre-established performance criteria.
• This equity award further aligns the CFO's financial interests with the long-term value creation for shareholders.

Future Outlook

The shares underlying the performance-based restricted stock units are scheduled to be delivered to the Reporting Person on or about March 15, 2026.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance metrics is a common practice in the healthcare and technology sectors, aiming to align management incentives with shareholder returns. This particular award reflects the company's compensation strategy for its Chief Financial Officer.

Comparison to Industry Standards

• Performance-based restricted stock units are a standard component of executive compensation packages across various industries, including healthcare tech, similar to practices at companies like Teladoc Health or GoodRx.
• The grant of 410,690 shares to a CFO is a substantial award, comparable in scale to significant equity grants seen at growth-oriented technology companies for key executives upon achieving specific operational or financial milestones.

Stakeholder Impact

• Shareholders: Increased alignment of CFO's interests with shareholder value due to significant equity award.
• Employees: May signal positive internal performance and achievement of company goals.

Next Steps

• Delivery of the shares underlying the PRSUs to the Reporting Person on or about March 15, 2026.

Key Dates

Recommendation

The filing reports an expected executive compensation event where performance targets were met, which is a minor positive for company operations and management alignment. However, it does not provide sufficient new information to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Hims & Hers Health, HIMS, Oluyemi Okupe, CFO, Form 4, Insider Transaction, Restricted Stock Units, Performance-Based Equity, Executive Compensation, Stock Award